Luma Light System Proof of Concept Study in Subjects With Mild to Moderate Psoriasis

Inclusion Criteria

• •Male or female of any race, 18 to 65 (inclusive) years of age.
• •Verbal and written informed consent obtained from the subject.
• •Has a clinical diagnosis of mild to moderate psoriasis at the Screening and Baseline visits.
• •Has an IGA score of 2 or 3.
• •Target plaque assessment (TPA) score between 6-9 and a score of at least 2 for each of the 3 different psoriasis signs and symptoms (erythema, plaque elevation, and scaling)
• •Has at least 4 plaques of at least 10 cm2 with TPA scores not differing from each other by a score of more than 1
• •Is in good general health as determined by the Investigator based on the subject's medical history, vital signs and physical examination.
• •Females of childbearing potential must have negative urine pregnancy test results.
• •Females of childbearing potential agree to use acceptable methods of contraception from the screening visit continuously until 30 days after end of treatment.
• •Subject agrees to use only the Sponsor provided cleanser and lotion during the study period.
• •Subject is willing and able to return for all study visits.